Leena Bhasin, MD
Internal Medicine · Birmingham, ALNPI 1578770152
Payments from drug & device makers
Across 101 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$496
- Johnson & Johnson$373
- Pfizer$243
- E.r. Squibb & Sons, L.L.C.$165
- Gilead$101
- Boehringer Ingelheim$98
- plus $379 from 11 others
What the payments were for
- Food & beverage$1,855100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 30 | $496 |
| Johnson & Johnson | 20 | $373 |
| Pfizer | 13 | $243 |
| E.r. Squibb & Sons, L.L.C. | 10 | $165 |
| Gilead | 4 | $101 |
| Boehringer Ingelheim | 4 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $96 |
| AstraZeneca(2 entities) | 4 | $75 |
| AbbVie(2 entities) | 3 | $57 |
| Portola Pharmaceuticals, LLC | 2 | $27 |
| Chiesi USA, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $16 |
| Mylan Specialty L.p. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$1,855 in reported general payments places this provider in the 70th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 53 | $1,097 |
| Prednisone | 38 | $379 |
| Cefdinir | 31 | $335 |
| Fluconazole | 22 | $269 |
| Atorvastatin Calcium | 21 | $226 |
| Lorazepam | 16 | $224 |
| Pantoprazole Sodium | 25 | $215 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $212 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $211 |
| Amlodipine Besylate | 35 | $193 |
| Hydralazine Hcl | 19 | $168 |
| Doxycycline Hyclate | 18 | $154 |
| Tramadol Hcl | 14 | $153 |
| Ciprofloxacin Hcl | 13 | $131 |
| Potassium Chloride | 14 | $129 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Birmingham
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- William KirbyBirmingham$2.3M
- Jordan VaughnBirmingham$1.6M
- Stefanie KrickBirmingham$527K
- Ryan WeldonBirmingham$458K
- Ashraf KhanBirmingham$215K
- Robert LewisBirmingham$201K
- David WynneBirmingham$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.